Medisafe Carezone: PillMemo is a medication reminder and adherence tracking app for iOS users managing daily prescriptions or vitamins.
Product velocity
Dormant
Daily rank 🇺🇸
—
Medical
Sentiment
4.9
12 reviews
Nemesis
NimbleRx
The App DNA
What makes this app unique?
The app removes the cognitive load of manual pill tracking by automating daily alerts and providing a shared health view for caregivers.
For Individuals managing daily vitamins or complex prescription plans, and caregivers supporting family members with medication adherence.
Key features
Logs daily intake and dosage schedules.
Enables secure adherence data sharing with caregivers.
Tracks pill counts and provides refill reminders.
How much does it cost?
Strict usage caps on the free tier force conversion for users with more than one medication.
Velocity
Dormant developmentopaqueShow more...
The app has not received a release in over 8 months, falling well outside the threshold for active development. The only available data point is a minor update from September 2025, which provided only generic bug fixes and usability improvements. There is no evidence of ongoing feature development, live operations, or maintenance cycles. The development status is classified as zombie due to the prolonged period of inactivity.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Medisafe Carezone: PillMemo
How's the Medical market?
Medisafe Carezone: PillMemo operates in the Medical category with a 4.9-star rating based on 12 reviews. The restrictive free tier limits the user base to single-medication users, placing it at a disadvantage against rivals that offer broader free-tier utility.
Read the market outlookThe rivals identified
By NimbleRx
NimbleRx competes directly by capturing the full medication lifecycle, moving beyond simple reminders into prescription fulfillment and pharmacy logistics.
- Integrated prescription delivery and pickup services provide a complete end-to-end pharmacy experience for users.
- Advanced price comparison tools allow users to find the lowest cost for their specific prescriptions.
- Massive scale and established pharmacy partnerships create a high barrier to entry for smaller competitors.
WellViewContender
GLP 1 Tracker - Within ReachContender
Blood Sugar Glucose TrackerContender
Gout Diet - Acid Uric TableContenderUnlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Medisafe Carezone: PillMemo
Where is it heading?
The medication-reminder market is consolidating around apps that offer integrated pharmacy logistics and chronic condition management. Medisafe Carezone: PillMemo remains in a maintenance state, which leaves it vulnerable to rivals that provide more utility for complex prescription plans.
- The 8-month development gap indicates a lack of active investment, which erodes the competitive position against rivals with frequent update cadences.
The SWOT
- Health-sharing mechanism enables caregiver adherence monitoring
- Inventory management prevents medication gaps
- Localized pricing in high-ARPU markets
Next best moves
Expand free tier to three medications because current one-pill limit forces immediate churn → increase top-of-funnel conversion
+ 1 more prioritized moveThe counter-intuitive read
The app's maintenance-mode status is a strategic advantage…
Read the full takeFeature gaps
Prescription fulfillment and pharmacy logistics (available in NimbleRx but absent here)
Since the last report: The product strategy shifted from internal feature polish to a defensive growth posture, specifically targeting the one-medication free-tier limit as the primary driver of user churn.
Bottom line
Medisafe Carezone: PillMemo must pivot its free-tier strategy to capture multi-medication users, as the current restriction limits the funnel to a narrow segment. Expanding access would unlock the growth needed to justify a return to active development.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated